Two women, same breast cancer diagnosis, different treatments: How tumour biology decides who needs chemotherapy
This article explains how modern oncology uses tumour biology and genetic markers to personalize breast cancer treatments rather than relying on a one-size-fits-all approach. It highlights how specific protein and hormone receptors dictate whether a patient requires chemotherapy or hormone-based therapies.
Why it matters
Understanding the biological basis of cancer treatment helps patients and families navigate complex medical decisions and reduces anxiety regarding treatment variations.
Two women walk into a clinic on the same morning. Both are in their late forties. Both have just been told they have breast cancer, and on their mammograms the lumps look almost identical.Within weeks, their paths split. One is scheduled for surgery, to be followed by a daily hormone tablet. The other begins chemotherapy.To patients and families, the gap can feel alarming. Did the doctors miss something? Is one woman being under-treated? In most cases, the answer is no. The difference lies in biology that a mammogram cannot show.Not one disease, but many“Breast cancer” is an umbrella term for several diseases that share an organ but behave very differently.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in